Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Cash

by Benzinga Staff
June 4, 2012 3:39 AM | 27 seconds read | Make a Comment

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash.Dendreon Corp (NASDAQ: DNDN) had $497.54 million in total cash and $573.82 million in total debt for the latest quarter.ViroPharma Inc (NASDAQ: VPHM) had $473.36 million in total cash and $155.46 million in total debt for the latest quarter.Momenta Pharmaceuticals Inc (NASDAQ: MNTA) had $382.26 million in total cash and no debt for the latest quarter.Nektar Therapeutics (NASDAQ: NKTR) had $382.11 million in total cash and $228.85 million in total debt for the latest quarter.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Trading IdeasBiotechnology Industryhighest cashSmall capssmall-cap

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.